Carregant...
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
BACKGROUND: High-dose short-term methylprednisolone is the recommended treatment in the management of multiple sclerosis relapses, although it has been suggested that lower doses may be equally effective. Also, glucocorticoids are associated with multiple and often dose-dependent adverse effects. Th...
Guardat en:
| Publicat a: | BMC Neurol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609048/ https://ncbi.nlm.nih.gov/pubmed/26475456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0450-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|